Graft and systemic disease in long-term survivors of liver transplantation

Hepatology

Volumn 25, Issue 1, 1997, Pages 195-202

  Slapak, Gabriella I ^a   Saxena, Romil ^a   Portmann, Bernard ^a   Gane, Edward ^a   Devlin, John ^a   Calne, Sir Roy ^b   Williams, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BUDD CHIARI SYNDROME; CHILD; CHOLANGITIS; DIALYSIS; DRUG MIXTURE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0031021338     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250136     Document Type: Article

References (35)

1. Belle SH, Detre KM. Report from the Pitt-UNOS Liver Transplant Registry. Transplant Proc 1993;25:1137-1142.
2. The European Liver Transplant Registry Report. Villejuif: Hôpital Paul Brousse, December, 1994.
3. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC. The pathology of liver grafts surviving beyond one year. HEPATOLOGY 1990;3: 465-470.
4. Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, et al. Late graft loss after liver transplantation: a study of 434 consecutive patients. Transplant Proc 1993;25:1111-1112.
5. McCaughan GW, O'Brien E, Sheil AGR. A follow-up of 53 adult patients alive beyond 2 years following liver transplantation. J Gastroenterol Hepatol 1993;8:569-573.
6. Pappo O, Ramos H, Starzl T, Fung J, Demetris A. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19:192-206.
7. Review Guideline. Summary of 1993 WHO/ISH guidelines for the management of mild hypertension. Br Med J 1994;308:470-473.
8. Portmann B, Neuberger JM. Disease recurrence (viral and other disorders). In: Williams R, Portmann B, Tan KC, eds. The Practice of Liver Transplantation. London and Edinburgh; Churchill Livingstone, 1995; 245-257.
9. Gane EJ, Portmann BC, Smith HM, Tibbs CJ, Naoumov NV, Williams R. Hepatitis C virus infection after liver transplantation (OLT) is associated with severe graft disease. J Hepatol 1995;22:21.
10. Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995;22(suppl 1):154-159.
11. Wright HL, Bou-Abboud C, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH. Disease recurrence following transplantation for auto-immune chronic active liver disease. Transplantation 1992;53:136-139.
12. Portmann B, Popper H, Neuberger J, Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985;88:1777-1790.
13. Neuberger JM, Portmann B, Macdougall B, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982;306:1-4.
14. Polson R, Portmann B, Neuberger JM, Calne RY, Williams R. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 1989;97:715-725.
15. Balan V, Batts KP, Porayko MK, Krom RAF, Ludwig J, Wiesner RH. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. HEPATOLOGY 1993;18:1392-1398.
16. Hubscher SG, Elias E, Buckels JAC, Mayer D, McMaster P, Neuberger JM. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18:173-184.
17. Wong P, Portmann B, O'Grady J, Devlin JJ, Hegarty JE, Tan K-C, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation following FK506 based immunosuppression. J Hepatol 1993;17:284-287.
18. Devlin J, Slapak G, Portmann B, Williams R. Immunosuppression withdrawal in long-term liver recipients [Abstract]. HEPATOLOGY 1994;20: 124A.
19. Calne RY. A new technique for biliary drainage in orthotopic liver transplantation utilising the gallbladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg 1977;184:605-609.
20. McMaster P, Walton RM, White DG, Medd RK, Syrakos TP. The influence of ischaemia on the biliary tract. Br J Surg 1980;67:321-324.
21. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? HEPATOLOGY 1994;20:356-361.
22. Brixto C, Wall SD, Ferrell L. Evidence for recurrence of primary sclerosing cholangitis after orthotopic liver transplantation [Abstract]. HEPATOLOGY 1993;18:325A.
23. Li S, Stratta RJ, Langnas AN, Wood RP, Marujo W, Shaw BW. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992; 164:536-540.
24. Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995;19:81-90.
25. Naber AHJ, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991;12:94-99.
26. Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. Azathioprine and hepatic veno-occlusive disease in renal transplant recipients. Gastroenterology 1986;90:446-454.
27. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. HEPATOLOGY 1994;20:88-94.
28. Wanless I, Godwin T, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative venopathy. Medicine 1980;59:367-379.
29. Maia de Souza J, Portmann B, Williams R. Nodular regenerative hyperplasia of the liver and the Budd-Chiari syndrome. HEPATOLOGY 1991;12:28-35.
30. Haboubi N, Ali H, Whitwell H, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-261.
31. Mazzaferro V, Porter KA, Scotti-Foglieni CL, Venkataramanan R, Makowka L, Rossaro L, Francavilla A, et al. The hepatotrophic influence of cyclosporin. Surgery 1990;107:533-539.
32. Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE. Augmentation of rat liver regeneration by FK506 compared with cyclosporin. Lancet 1989;2:1248-1249.
33. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical Treatment of HCC; experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
34. McPeake JR, O'Grady J, Zaman S, Portmann B, Wight DGD, Tan KC, Calne RY, et al. Liver transplantation for primary hepatocellular carcinoma: tumour size and number determine outcome. J Hepatol 1993;18: 226-234.
35. Sheil AGR. Malignancy following liver transplantation - a report from the Australian combined Liver Transplant Registry. Transpl Proc 1995;27: 1247.